Compagnie Lombard Odier SCmA’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $669K | Buy |
25,245
+5,000
| +25% | +$133K | 0.01% | 170 |
|
|
2025
Q1 | $489K | Buy |
20,245
+15,000
| +286% | +$362K | 0.01% | 199 |
|
|
2024
Q4 | $211K | Buy |
5,245
+245
| +5% | +$9.86K | ﹤0.01% | 237 |
|
|
2024
Q3 | $317K | Hold |
5,000
| – | – | ﹤0.01% | 208 |
|
|
2024
Q2 | $265K | Hold |
5,000
| – | – | ﹤0.01% | 218 |
|
|
2024
Q1 | $410K | Buy |
+5,000
| New | +$410K | 0.01% | 202 |
|